Affymax Rises as FDA Panel Backs Anemia Drug - Dec. 08, 2011

Having trouble viewing this email? View in Browser.

Thursday, December 08, 2011  |   |   |   |  Third Annual X-Gen Congress & Expo March 5-8, 2012 | San Diego, California www.XGenCongress.com Join us March 5-8, 2012 in San Diego, California to apply both established and emerging genomic technologies and discover why data is the driving force that enables these genomic discoveries. Leveraging these discoveries continues to impact the prevention, detection, and treatment of disease. Programs are organized and designed for you to attend sessions relevant to your unique research needs. Special early registration discounts are available until Friday, December 9. Don't miss this opportunity to take advantage of reduced registration rates and save up to $350.   •  Affymax, Inc. (AFFY) Rises as FDA Panel Backs Anemia Drug More... •  Genentech (RHHBY)'s Two-Drug Strategy Raises the Bar in Breast Cancer, Positive Phase III Results Reported More... •  Latest Data on Novartis AG (NVS) Afinitor Confirms Efficacy More... •  Forbion Capital Raises $50 Million to Invest in Health Companies More... •  FDA OKs Antares Pharma, Inc. (AIS) Overactive Bladder Gel More... •  Alexza Pharmaceuticals, Inc. (ALXA) Inhaled Antipsychotic May Pose Fatal Lung Risks, FDA Review More... •  FDA: Boehringer Ingelheim Corporation's Pradaxa Benefit Outweighs Bleeding Risk More... •  AstraZeneca PLC (AZN) Digs Deeper in China With Generics Buy More... More Top News Scottish Development International: The home of whisky and the bionic hand, we're the toast of the scientific community. Independent analysis shows that Scotland is a high quality, cost effective location to establish your business project. Enter your details to access our FREE Financial Times benchmarking reports on a range of industries that demonstrate Scotland's competitiveness. •  Obama Administration Keeps Limit on Teva Pharmaceutical Industries Limited (TEVA) Morning-After Pill, Marks First Time US Overrules FDA More... •  Why Aren't We Smarter Already? Evolutionary Limits on Cognition, University of Warwick and University of Basel Study More... •  New Sugar May Prevent Heart Disease, University of Melbourne Study More... •  Marathon Training "May Pose a Heart Risk," University of Melbourne Study More... •  Intermittent, Low-Carbohydrate Diets More Successful Than Standard Dieting, University Hospital in South Manchester Study More... •  Vaccine Might One Day Prevent "Cruise Ship" Stomach Bug, Baylor College of Medicine Study More... •  Bottle Brush Molecules Filter Impurities, University at Buffalo Study More... •  False Alarm Can Spark Autoimmune Disease, Cornell University Study More...   More Featured News Better Antibodies Through Better Antigen Design Join SDIX at the Boston Cambridge Marriott on December 8th, 2011 for a symposium focused on next generation antibody development. At SDIX, a focus on the philosophy of better antigen design has resulted in dramatic improvements to the antibody production process. In a series of talks, our scientists and collaborators will discuss this antigen design philosophy and provide case studies to demonstrate the effectiveness of this methodology. In particular, these talks will focus on the use of SDIX's proprietary Genomic Antibody Technology™ and its ability to deliver antibodies that match end users' requirements. Please click here for more information. Pharmacoeconomic Analysis in R&D Decision Making • Understand the importance of health technology assessment in reimbursement decisions and how to optimize data to get a positive outcome. • Compare different methods that use health economics early in product development and can enable decisions to be made that will reduce R&D costs. • Understand how trials can be designed to provide good evidence to support positive reimbursement decisions. • Understand the impact of increasing interaction between the various stakeholders in the reimbursement decision making process. Click Here for More Information. Quantifying the Value of Pipeline Pilot, the Accelrys Scientific Enterprise Platform This white paper outlines the methodology, sources of value, and quantifiable results from bringing products to market faster, avoiding unproductive experiments, saving developer time, and more. Request Now! • BioTechxus (Houston, Texas) Bellicum Pharmaceuticals Research Scientist Responsible for the conduct and oversight of projects within the oncology immunotherapy program using cutting edge technologies. The candidate will develop relevant in vitro and in vivo oncology models and perform the testing of therapeutic candidates in the disease models. • Southern Pharm (Clarkston, Georgia) Diagnostica Stago, Inc. Product Development Manager Manage, develop and maintain the companies IVD products. Act as SME for all products as they relate to product development including but not limited to Design control management and transfer process, Device history management, Change control, Verification, Validation, Optimization testing and Stability studies, and translation of technical information. • Biotech Bay (San Francisco, California) UGL Services Health, Safety, & Environmental Manager Functions as a national safety leader for the Life Sciences client accounts by instilling safety as a cultural value and working throughout the Life Sciences organization to create an injury free work environment for UGL Services and for Life Sciences employees, visitors and contractors. • BioMidwest (Madison, Wiconsin) Promega Corporation Facilities Leader Responsible for providing overall leadership for facilities related initiatives and projects. This role will manage multiple diverse and complex projects concurrently across the organization, including campus maintenance, new construction, and overall facilities strategy. • Pharm Country (Utica, New York) ICON Clinical Research, Inc. Scientific Laboratory Manager Responsible for the coordination and oversight of all immunogenicity testing, including electrochemiluminescence assays, ELISAs and cell-based assays to include cell-based neutralizing assays. Work closely with customers to assist in the transfer, development and validation of these types of assays in a GxP-compliant manner. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! BioSpace Life Science Career Fairs are the biotech industry's premier career events. Featuring well-respected employers from around the nation, our job fairs attract top candidates in the biotech, pharmaceutical, life science and medical device industries. With such a great number of recruiters and hiring managers from top biotech companies attending our career fairs, there are an abundance of opportunities available for job seekers. Many different disciplines within the industry are represented bringing a diversity of candidates to our job fairs. Companies seeking pharmaceutical sales representatives and marketing jobs regularly attend our job fairs. Engineering and technical jobs can be found, as well as regulatory jobs and positions in QA/QC. Individuals desiring a science job or a research job will find many opportunities at our job fairs. In addition, hiring managers seeking candidates for clinical research jobs also attend our events. More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Alder Biopharmaceuticals Inc. Corporate Headquarters 11804 North Creek Parkway South Bothell, Washington 98011 U.S.A. Phone: 425-205-2900 Fax: 425-205-2901 Alder is revolutionizing the way antibody therapies are identified, selected, developed and produced. Our proprietary technologies make great strides possible in the field of antibody therapeutics, dramatically accelerating the way pharmaceutical and biotechnology companies bring new therapies to market. More Company Profiles FREE Subscription to Biodiesel Magazine Biodiesel Magazine is known throughout the biodiesel industry for its authoritative plant construction lists, compelling profiles and engaging features on production, fleet vehicle use, research, science, technology, marketing and policy. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.